{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:10:41Z","timestamp":1791475841060,"version":"4.3.4"},"reference-count":85,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>While targeting elevated serum levels of low-density lipoprotein cholesterol has been the mainstay of atherosclerosis prevention and treatment for decades, the evidence regarding the atherogenic role of hypertriglyceridemia is still controversial. Various epidemiological population-based studies on statin-treated subjects nominated triglycerides, triglyceride-rich lipoproteins (namely, chylomicrons and very-low-density lipoprotein particles), and their remnants as major determinants of the substantial residual cardiovascular risk. With the triglyceride-glucose index and triglyceride to high-density lipoprotein ratio emerging as surrogate indicators of peripheral artery disease and atherosclerotic cerebrovascular disease, one can conclude that further research addressing the intricate relationship between triglycerides and atherosclerosis is warranted. Therefore, this review aims to provide insight into the current clinical and epidemiological state of knowledge on the relationship between triglycerides and atherosclerotic cardiovascular disease. It also intends to highlight the connection between triglycerides and other metabolic disorders, including diabetes mellitus, and the potential benefits of triglyceride-lowering agents on cardiovascular outcomes and all-cause mortality.<\/jats:p>","DOI":"10.3390\/nu13061774","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:01:20Z","timestamp":1621814480000},"page":"1774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Radu","family":"Sasc\u0103u","sequence":"first","affiliation":[{"name":"Internal Medicine Department, \u201dGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Clement","sequence":"additional","affiliation":[{"name":"Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Radu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201dGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Prisacariu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201dGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-4561","authenticated-orcid":false,"given":"Cristian","family":"St\u0103tescu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201dGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107592","DOI":"10.1016\/j.pharmthera.2020.107592","article-title":"Lipid lowering therapy in cardiovascular disease: From myth to molecular reality","volume":"213","author":"Mourikis","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijcard.2016.11.061","article-title":"The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors","volume":"228","author":"Hartman","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_4","unstructured":"Carroll, M., Kit, B., and Lacher, D. (2015). Trends in Elevated Triglyceride in Adults: United States, 2001\u20132012, National Center for Health Statistics, United States of America (USA). NCHS Data Brief."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacl.2020.04.009","article-title":"The association between triglycerides and incident cardiovascular disease: What is \u201coptimal\u201d?","volume":"14","author":"Aberra","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/eurheartj\/ehz778","article-title":"Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: Why these results usher in a new era in dyslipidaemia therapeutics","volume":"41","author":"Boden","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1253\/circj.CJ-19-0981","article-title":"Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients under Statin Therapy","volume":"84","author":"Tada","year":"2020","journal-title":"Circ. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/2047487319898571","article-title":"Association of four lipid components with mortality, myocardial infarction, and stroke in statin-na\u00efve young adults: A nationwide cohort study","volume":"27","author":"Lee","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2020.11.038","article-title":"Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years","volume":"142","author":"Kaneko","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","article-title":"Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk","volume":"76","author":"Burnett","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2020.04.021","article-title":"ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents","volume":"302","author":"Krysa","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MED.0000000000000468","article-title":"Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis","volume":"26","author":"Generoso","year":"2019","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and Consequences of Hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: A triumph of simplicity","volume":"27","author":"Williams","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11883-020-00846-8","article-title":"Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions","volume":"22","author":"Hussain","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2005.12.013","article-title":"The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma","volume":"367","author":"Nakajima","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin. Chim. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","article-title":"Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: Prevention by cilostazol","volume":"109","author":"Shin","year":"2004","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1194\/jlr.M200322-JLR200","article-title":"ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan","volume":"43","author":"Krauss","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI30889","article-title":"Atherogenic remnant lipoproteins: Role for proteoglycans in trapping, transferring, and internalizing","volume":"117","author":"Mahley","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MOL.0000000000000682","article-title":"Remnant lipoproteins: Are they equal to or more atherogenic than LDL?","volume":"31","author":"Salinas","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1194\/jlr.M700505-JLR200","article-title":"Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation","volume":"50","author":"Wang","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.102.6.670","article-title":"Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism","volume":"102","author":"Doi","year":"2000","journal-title":"Circulation"},{"key":"ref_25","first-page":"344","article-title":"Characterization of the effect of plasma lipoproteins on platelet function in vitro","volume":"13","author":"Aviram","year":"1983","journal-title":"Haemostasis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000093221","article-title":"Effects of VLDL and remnant particles on platelets","volume":"35","author":"Olufadi","year":"2006","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13059","article-title":"Contribution of remnant cholesterol to cardiovascular risk","volume":"288","author":"Langsted","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_28","unstructured":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), and ESC National Cardiac Societies (2019). 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140\u2013205."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/2047487319894114","article-title":"Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease","volume":"27","author":"Feng","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2019.03.004","article-title":"Triglycerides and cardiovascular risk: Apolipoprotein B holds the key","volume":"284","author":"Stock","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hussain, A., Sun, C., Selvin, E., Nambi, V., Coresh, J., Jia, X., Ballantyne, C.M., and Hoogeveen, R.C. (2021). Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur. J. Prev. Cardiol.","DOI":"10.1093\/eurjpc\/zwaa152"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejvs.2015.12.045","article-title":"Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The REGICOR Study","volume":"51","author":"Velescu","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/ATVBAHA.120.315828","article-title":"Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease","volume":"41","author":"Kou","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Toth, P.P., Hull, M., Granowitz, C., and Philip, S. (2020). Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database. Future Cardiol.","DOI":"10.2217\/fca-2020-0123"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12944-020-01407-3","article-title":"Association between nontraditional lipid profiles and peripheral arterial disease in Chinese adults with hypertension","volume":"19","author":"Ding","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-019-0893-2","article-title":"Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care","volume":"18","author":"Caldas","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hong, S., Han, K., and Park, C.Y. (2020). The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: A population-based study. BMC Med., 18.","DOI":"10.1186\/s12916-020-01824-2"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3906\/sag-2006-180","article-title":"The triglyceride-glucose index predicts peripheral artery disease complexity","volume":"50","author":"Ayhan","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1708538120923531","article-title":"Is it possible to predict the complexity of peripheral artery disease with atherogenic index?","volume":"28","author":"Mesut","year":"2020","journal-title":"Vascular"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2020.08.030","article-title":"The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease","volume":"322","author":"Heidemann","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease","volume":"75","author":"Duran","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ana.25916","article-title":"Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke","volume":"88","author":"Yuan","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12933-020-01031-6","article-title":"High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: A cross-sectional study","volume":"19","author":"Nam","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fneur.2020.00456","article-title":"Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.endonu.2016.04.004","article-title":"Association between triglyceride\/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women","volume":"63","author":"Masson","year":"2016","journal-title":"Endocrinol. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Nam, K.W., Kwon, H.M., Jeong, H.Y., Park, J.H., Kwon, H., and Jeong, S.M. (2019). High triglyceride\/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1373-8"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.numecd.2020.05.009","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population","volume":"30","author":"Zhou","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"105351","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105351","article-title":"The Atherogenic Index of Plasma is Independently Associated with Symptomatic Carotid Artery Stenosis","volume":"29","author":"Garg","year":"2020","journal-title":"J. Stroke Cerebrovasc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12944-020-01360-1","article-title":"Atherogenic index of plasma predicts cerebrovascular accident occurrence in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"Ahn","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jacc.2020.09.583","article-title":"The Effect of Blood Lipids on the Left Ventricle: A Mendelian Randomization Study","volume":"76","author":"Aung","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","first-page":"1206217","article-title":"Review of Echocardiographic Findings in Patients with Obstructive Sleep Apnea","volume":"2018","author":"Zota","year":"2018","journal-title":"Can. Respir. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_55","first-page":"4219180","article-title":"Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malm\u00f6 Diet and Cancer Study","volume":"2020","author":"Hartz","year":"2020","journal-title":"Int. J. Vasc. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"L\u0103c\u0103tu\u0219u, C.M., Grigorescu, E.D., St\u0103tescu, C., Sasc\u0103u, R.A., Onofriescu, A., and Mihai, B.M. (2019). Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients. Medicana, 55.","DOI":"10.3390\/medicina55090592"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"108150","DOI":"10.1016\/j.diabres.2020.108150","article-title":"Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community dwelling adults: A longitudinal 12-year analysis of the Korean Genome and Epidemiology Study","volume":"163","author":"Lim","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12944-020-01403-7","article-title":"Association between triglyceride-glucose index and risk of incident diabetes: A secondary analysis based on a Chinese cohort study: TyG index and incident diabetes","volume":"19","author":"Li","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3613041","DOI":"10.1155\/2020\/3613041","article-title":"Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects with Type 2 Diabetes: The AMD Annals Initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e016947","DOI":"10.1161\/JAHA.120.016947","article-title":"Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study","volume":"10","author":"Kaze","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-020-01340-3","article-title":"Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: Role of plasma triglycerides","volume":"44","author":"Mantovani","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Anghel, L., Sasc\u0103u, R., Radu, R., and St\u0103tescu, C. (2020). From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061920"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00019501-200403000-00008","article-title":"Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia","volume":"15","author":"Hunninghake","year":"2004","journal-title":"Coron. Artery Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/13543784.2020.1764937","article-title":"Novel emerging therapies in atherosclerosis targeting lipid metabolism","volume":"29","author":"Gupta","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/14779072.2020.1768848","article-title":"Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia","volume":"18","author":"Nurmohamed","year":"2020","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/dom.13686","article-title":"Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study","volume":"21","author":"Araki","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"521","DOI":"10.5551\/jat.44412","article-title":"Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial","volume":"25","author":"Arai","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2796.2008.02062.x","article-title":"Ezetimibe monotherapy for cholesterol lowering in 2722 people: Systematic review and meta-analysis of randomized controlled trials","volume":"265","author":"Pandor","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MED.0000000000000530","article-title":"Triglycerides and residual risk","volume":"27","author":"Corral","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.acvd.2020.04.004","article-title":"The return of triglycerides and revival of omega-3 fatty acids!","volume":"113","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2020.08.015","article-title":"REDUCE-IT Eligibility and Preventable Cardiovascular Events in the US Population (from the National Health and Nutrition Examination Survey [NHANES])","volume":"134","author":"Wong","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2020.07.013","article-title":"Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid","volume":"309","author":"Fukumoto","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12944-020-01280-0","article-title":"Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)","volume":"19","author":"Zhang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Taskinen, M.R., Bj\u00f6rnson, E., Kahri, J., S\u00f6derlund, S., Matikainen, N., Porthan, K., Ainola, M., Hakkarainen, A., Lundbom, N., and Fermanelli, V. (2020). Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects with Type 2 Diabetes. Arterioscler. Thromb. Vasc. Biol.","DOI":"10.1161\/ATVBAHA.120.315446"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MOL.0000000000000710","article-title":"Hypertriglyceridemia: New approaches in management and treatment","volume":"31","author":"Wolska","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S224771","article-title":"Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy","volume":"14","author":"Esan","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Taskinen, M.R., Bj\u00f6rnson, E., Matikainen, N., S\u00f6derlund, S., Pietil\u00e4inen, K.H., Ainola, M., Hakkarainen, A., Lundbom, N., Fuchs, J., and Thorsell, A. (2021). Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes. Diabetes Obes. Metab.","DOI":"10.1111\/dom.14328"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"644","DOI":"10.5551\/jat.50807","article-title":"Empagliflozin\u2019s Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease","volume":"27","author":"Sawada","year":"2020","journal-title":"J. Atheroscler. Thromb."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/6\/1774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:13Z","timestamp":1760162773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/6\/1774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":85,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["nu13061774"],"URL":"https:\/\/doi.org\/10.3390\/nu13061774","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]}}}